Impact of heart failure on the clinical profile and outcomes in patients with atrial fibrillation treated with rivaroxaban. Data from the EMIR studyManuel Anguita Sánchez, Marcelo Sanmartı́n, Jaime Masjuán et al.|Cardiology Journal|2022Cited by 3